| abstract |
The invention relates to a gastric acid inhibitor and gastric acid inhibitor composition, which is an orally disintegrating tablet, and comprises the following materials in parts by weight: 0.5 to 30 percent of API, 10 to 80 percent of MCC, 10 to 80 percent of auxiliary material, 2 to 70 percent of filling agent, 1 to 10 percent of adhesive, 1 to 10 percent of disintegrating agent, 0.1 to 5 percent of magnesium stearate, 0.1 to 10 percent of sucralose, 0.1 to 10 percent of aspartame and 0.1 to 10 percent of spice. The orally disintegrating tablet prepared by the invention has the advantages of short disintegration time and light bitter taste, is convenient for patients to take, has strong taking compliance, and is particularly suitable for children patients, old patients and patients with swallowing dysfunction. |